Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
NCT05417776Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2022
- Primary completion
- Oct 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Gallium Ga 68 NODAGA-CBP8 in interstitial lung disease (ILD), sponsored by Massachusetts General Hospital. Started Sep 2022; status: recruiting.
02
Drugs
Gallium Ga 68 NODAGA-CBP8
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT05417776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05417776.